BridgeMD
New treatment option for Chronic Constipation
Official title Exploring the Potential Benefits of Probiotic Yogurt
ClinicalTrials.gov ID: NCT06847919
What this study is testing
- What it's testing
- This study aims to evaluate the effect of a high-activity probiotic yogurt on improving symptoms of chronic constipation, observing its regulatory effects on the gut microbiota and the incidence of adverse reactions in study participants over a 21-day intervention period.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Meet the Rome IV diagnosis criteria for chronic constipation;
- Patients who are able to understand clinical studies and are committed to complying with study requirements and procedures;
- Age 18-65. -
You likely can't join if
- Systemic (diabetes, autoimmune diseases, cancer), gastrointestinal or liver diseases known to be associated with alterations in the gut microbiota;
- Patients who are pregnant or lactating;
- have taken antimicrobials, probiotics, or drugs that inhibit stomach acid or gastrointestinal motility in the past 6 weeks;
- Patients who changed their diet type during the study;
- Patients who are allergic or intolerant to any component of the investigational product formulation;
- Patients with cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and other serious diseases and endocrine diseases, mental...
See the full eligibility criteria
- Meet the Rome IV diagnosis criteria for chronic constipation;
- Patients who are able to understand clinical studies and are committed to complying with study requirements and procedures;
- Age 18-65. -
- Systemic (diabetes, autoimmune diseases, cancer), gastrointestinal or liver diseases known to be associated with alterations in the gut microbiota;
- Patients who are pregnant or lactating;
- have taken antimicrobials, probiotics, or drugs that inhibit stomach acid or gastrointestinal motility in the past 6 weeks;
- Patients who changed their diet type during the study;
- Patients who are allergic or intolerant to any component of the investigational product formulation;
- Patients with cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and other serious diseases and endocrine diseases, mental patients;
- Stop taking the tested sample or add other drugs in the middle, unable to judge the how well it works or incomplete data;
- short-term use of objects related to the function of the test, affecting the judgment of the result;
- have been dieting, exercising excessively, taking weight loss medications or taking medications that may affect appetite in the past 3 months;
- Current or past excessive use of alcohol, drugs, or supplements that may cause intestinal dysfunction or interfere with the evaluation of the how well it works of the study product -
The study team makes the final eligibility decision.
Where it's taking place
- Suzhou, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suzhou, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.